Psoriasis Special Focus – JDD August Highlights and Editor Picks
August JDD Cover Image PsoriasisHave you received your August issue of the JDD yet?  This month's issue contains a special focus on Psoriasis, as August is Psoriasis Awareness Month!  Below are the issue highlights and Editor Picks for the August issue of JDD! In Long-Term Efficacy of Guselkumab for the Treatment of Moderate-to-Severe Psoriasis: Results from the Phase 3 VOYAGE 1 Trial Through Two Years, high levels of effi …
August JDD Cover Image Psoriasis
January JDD Highlights
A Multi-Center, Open-Label, Prospective Study of Cannula Injection of Small-Particle Hyaluronic Acid Plus Lidocaine (SPHAL) for Lip Augmentation assesses the safety and effectiveness associated with the use of a blunt-tipped microcannula for lip augmentation and correction of perioral rhytids using a small-particle, hyaluronic acid gel plus lidocaine   Educating men about available aes …
JDD August Highlights – Special Focus: Psoriasis
Catch up on your JDD reading with highlights from the August issue, Special Focus: Psoriasis. Strober, Bagel, and Lebwohl et al present Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study   READ NOW The Static Physician’s Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Ps …
Off-Label Treatments for Papulosquamous Diseases: Insights from Dr. Adam Friedman
Papulosquamous DiseasesAt the 2025 ODAC Dermatology Conference, we had the privilege of hearing from Dr. Adam Friedman, a renowned expert in dermatology and the chair of the department of dermatology at the George Washington, as he shared his expert insights into the evolving landscape of off-label treatments for challenging dermatologic conditions. Dr. Friedman addressed the complexities of managing conditions such as …
Papulosquamous Diseases
Treatment of Advanced Basal Cell Carcinoma With Involvement of the Left Orbit
basal cell carcinomaINTRODUCTION Periocular basal cell carcinoma (BCC) is the most common eyelid malignancy concomitant with ocular morbidity and quality of life impact.1,2 Orbital invasion occurs in 2% of cases and poses challenges for management.1,3 JDD authors highlight a multidisciplinary approach to the treatment of advanced periocular BCC.   CASE JDD authors discuss a 56-year-old male who presente …
basal cell carcinoma
error

Enjoy this blog? Please spread the word :)